Pharmaceutical Industry Information Portal

HomeDiscovery and Development

Discovery and Development

The clinical trial for an original Russian lung cancer drug has started in China

The BIOCAD and Shanghai Pharmaceuticals Holding joint venture has announced the enrollment of the first Chinese patient in the Phase III international multicenter clinical trial...

А phase III study proven the efficacy of the bevacizumab biosimilar in patients with late stages of NSCLC

New results for Phase III study of BCD-021, a bevacizumab biosimilar, were presented as a poster at the European Society for Medical Oncology (ESMO)...

Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced enrollment of the first participants in...

The launch of R&D centre at BratskChemSyntez LLC

The R&D centre is tasked to optimise its substance manufacturing process and develop new unique molecules. The complex has modern and high-precision equipment that allows...

Russian scientists developed intestinal soluble capsules

Crohn's disease and ulcerative colitis are severe chronic bowel diseases for which there are no effective drugs yet. The main approach in their therapy...

Sputnik V demonstrates 94.8% efficacy against COVID during the vaccination in San Marino

The Russian Direct Investment Fund (RDIF) announces the real world data of the Ministry of Health of San Marino on the Russian Sputnik V...
spot_img

Expert Articles

spot_img